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GlycosaminoglycansVaccinia virus (VACV) strain WR can enter cells by a low pH endosomal pathway or direct fusion with the
plasma membrane at neutral pH. Here, we compared attachment and entry of ﬁve VACV strains in six cell
lines and discovered two major patterns. Only WR exhibited pH 5-enhanced rate of entry following neutral
pH adsorption to cells, which correlated with sensitivity to baﬁlomycin A1, an inhibitor of endosomal
acidiﬁcation. Entry of IHD-J, Copenhagen and Elstree strains were neither accelerated by pH 5 treatment nor
prevented by baﬁlomycin A1. Entry of the Wyeth strain, although not augmented by pH 5, was inhibited by
baﬁlomycin A1. WR and Wyeth were both relatively resistant to the negative effects of heparin on entry,
whereas the other strains were extremely sensitive due to inhibition of cell binding. The relative sensitivities
of individual vaccinia virus strains to heparin correlated inversely with their abilities to bind to and enter
glycosaminoglycan-deﬁcient sog9 cells but not other cell lines tested. These results suggested that that IHD-J,
Copenhagen and Elstree have a more limited ability than WR and Wyeth to use the low pH endosomal
pathway and are more dependent on binding to glycosaminoglycans for cell attachment.
Published by Elsevier Inc.Introduction
Poxviruses comprise a family of large DNA viruses that replicate
entirely in the cytoplasm of animal cells (Moss, 2007). Vaccinia virus
(VACV), the prototype poxvirus has a 195 kbp double-stranded DNA
genome that encodes nearly 200 proteins. There are two major
infectious forms of VACV, the mature virion (MV) and enveloped
virion (EV). MVs, which are comprised of a single membrane with
more than 20 viral proteins surrounding the virus core, can be
released by cell lysis. EVs are formed when a subset of MVs are
wrapped by modiﬁed trans-Golgi or endosomal cisterna containing
additional viral membrane proteins and are transported to the
periphery of the cell where they exit through the plasma membrane
(Smith et al., 2002). EVs differ from MVs primarily by the presence of
an extra membrane that contains at least six unique viral proteins.
This outer membrane is disrupted by cellular polyanionic molecules
on the cell surface to allow for fusion of the inner MVmembrane with
the cell and entry of the core (Law et al., 2006).
Virus attachment, activation of fusion proteins, and membrane
fusion comprise the typical steps involved in enveloped virus entry
(Earp et al., 2005). The majority of studies with VACV have been
carried out with the MV form. Attachment of MVs to glycosaminogly-
cans (GAGs) at the cell surface is mediated by three MV membrane
proteins A27, D8 and H3 (Chung et al., 1998; Hsiao et al., 1999; Lin
et al., 2000), but MVs can also enter cells in a GAG-independentInc.manner (Carter et al., 2005). Two additional MV membrane proteins,
A26 and L1, which bind to the extracellular matrix protein laminin and
to a putative unknown protein, respectively, have also been identiﬁed
(Chiu et al., 2007; Foo et al., 2009).
The entry fusion complex (EFC), comprising eight or more virus-
encoded MV membrane proteins, is required for the entry of VACV
(Izmailyan et al., 2006; Ojeda et al., 2006a, 2006b; Senkevich and
Moss, 2005; Senkevich et al., 2004, 2005; Townsley et al., 2005a,
2005b) and is also required for cell–cell fusion triggered by low pH or
mutation of the A56 or K2 proteins (Senkevich et al., 2004; Wagenaar
and Moss, 2007; Wagenaar et al., 2008). Additionally, the F9 and L1
proteins are essential for virion entry and associate with components
of the EFC in non-stoichiometric ratios (Bisht et al., 2008; Brown et al.,
2006). An eleventh protein, I2, has also been identiﬁed in VACV entry
though its association with the EFC has not yet been determined
(Nichols et al., 2008). Neither themechanism of fusion nor the roles of
the individual EFC and associated proteins have been elucidated.
Studies carried out with the Western Reserve (WR) strain of VACV
have shown that cell entry of MVs can occur via a low pH endosomal
pathway (Townsley et al., 2006) in addition to direct fusion at the
plasma membrane (Armstrong et al., 1973; Carter et al., 2005; Chang
andMetz,1976). However, earlier experiments with the IHD-J strain of
VACV indicated that MV entry was not inhibited by weak bases
suggesting independence of a low pH pathway (Vanderplasschen
et al., 1998). Here, we systematically compared the attachment and
entry of several VACV strains and found substantial differences with
regard to enhancement by low pH, requirement for endosome
acidiﬁcation, inhibition by soluble heparin and binding to cell surface
glycosaminoglycans.
Fig. 1. Entry of VACV strains. (A) BS-C-1 cells were incubated with VACV recombinant
luc strains at 4 °C at neutral pH for 1 h at a multiplicity of 1 plaque forming unit per cell,
followed by washing to remove unbound virus and exposure to pH 5 (black bars) or pH
7.4 (gray bars) buffer for 3 min at 37 °C. Cells were then washed and incubated at 37 °C
at neutral pH for 1 h. Cells were lysed and luc activity measured. (B) Fold enhancement
of low pHwas calculated by dividing the low pH relative luminescent units (RLU) by the
neutral pH RLU in panel A. Error bars are plotted in each case, though in some the
differences are too small to be resolved.
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Differential effects of low pH and inhibitors of endosomal acidiﬁcation on
entry of VACV strains
Previously, we prepared a recombinant VACV strainWR (WRvFire)
that expresses ﬁreﬂy luciferase (luc) regulated by an early–late
promoter to measure virus entry (Townsley et al., 2006). Luc activity
depends on virus attachment, fusion with the cell membrane,
transcription and translation. However, due to the packaging of the
transcription system within the virus core and the sensitivity of the
assay, a robust response is detected by 1 h after infection. Two types of
experiments suggested entry through a low pH endosomal route
(Townsley et al., 2006). First, brief exposure of cell-bound virions to
pH 5.0 buffer greatly increased luc expression during the ﬁrst hour. By
24 h, however, luc activity was only slightly higher than in the neutral
pH control. In addition, the low pH treatment had only a 1.4-fold
enhancing effect on plaque formation. Therefore, themain effect of the
brief low pH treatment was to accelerate rather than increase entry.
Second, luc expression was inhibited at neutral pH by drugs that
prevent endosomal acidiﬁcation.
To determine whether other VACV strains also use a low pH
endosomal route of entry, luc recombinants of the IHD-J (IHD-JvFire),
Copenhagen (CopvFire), Wyeth (WyethvFire) and Elstree (Elstreev-
Fire) strains were constructed. In each case, MVs were puriﬁed by
sucrose gradient centrifugation and titers were determined by plaque
assay. The protocol consisted of incubating virus with cells at 4 °C for
1 h to allow adsorption at neutral pH, removing unattached virus,
exposing the cells to buffer at pH 7.4 or 5.0 for 3 min at 37 °C, and then
continuing the incubation at 37 °C at neutral pH. After 1 h, the cells
were lysed and luc activity determined. (We emphasize that in all
experiments in this paper, whether explicitly stated or not, the
adsorption and 1 h incubation prior to measuring luc were at neutral
pH). Without post-absorption low pH exposure, luc was highest after
infection with IHD-J and Elstree (Fig. 1A). However, after low pH
treatment, luc expression by WR was similar to that of IHD-J and
Elstree (Fig. 1A). Although low pH greatly accelerated entry of WR, it
had little effect on IHD-J, Copenhagen, Wyeth or Elstree (Fig. 1B). A
longer experiment with IHD-J demonstrated superimposable
increases in luc activity with or without low pH exposure at all time
points reaching a maximum at about 10 h (data not shown). Thus, WR
appeared to be exceptional, relative to the other VACV strains tested,
with regard to low pH acceleration of entry.
Inhibition of endosomal acidiﬁcation by a speciﬁc inhibitor of the
vacuolar H+-ATPase, baﬁlomycin A1, reduces luc expression by WR
(Townsley et al., 2006). Baﬁlomycin A1 reduced entry of WR (Fig. 2A)
andWyeth (Fig. 2D) strains by about 50% at neutral pH in BS-C-1 cells,
but had little or no effect on IHD-J (Fig. 2B), Copenhagen (Fig. 2C) and
Elstree (Fig. 2E). As previously shown (Townsley et al., 2006) and
conﬁrmed here, low pH exposure largely annulled the effects of
baﬁlomycin A1 by inducing entry at the plasma membrane.
WRexhibits two lowpHactivation steps: pH5.0 pretreatment before
adsorption stably activates free virions for accelerated entry upon
addition to cells at neutral pH without altering the titer determined by
plaque assay, yet prevention of endosomal acidiﬁcation by baﬁlomycin
A1 is still inhibitory (Townsley andMoss, 2007). Compared to the other
strains tested, only WR exhibited accelerated luc expression after
exposure to low pHprior to adsorption to cells at neutral pH (Fig. 3). Luc
expression by theother strainswas either unaffected or slightly reduced.
The differences in low pH activation and the effects of baﬁlomycin A1
suggested strain variation in themode of entry of different VACV strains.
Entry of VACV in different cell types
The above experiments were carried out with BS-C-1 cells.
Employing WR and IHD-J as representatives of strains that differ intheir use of low pH mechanisms, we investigated entry in several
additional cell lines. Monkey kidney cells (BS-C-1 and Vero), rabbit
kidney cells (RK-13), marsupial potoroo kidney cells (PtK2), primary
human epidermal keratinocytes (HEKn) and a mutant mouse L cell
line defective in biosynthesis of GAGs (sog9) were incubated with
virus at neutral pH to permit adsorption and entry was measured
with and without subsequent exposure to low pH. Without pH 5
exposure, WR-induced higher luc expression in HEKn and PtK2 cells
than the other cell lines (Fig. 4A). However, pH 5-treatment
enhanced WR entry to the greatest extent in BS-C-1, RK-13 and
Vero cells and to lesser extents in the other cell lines (Figs. 4A, C).
Without low pH exposure, IHD-J induced high luc expression in all
cell lines except sog9 (Fig. 4B). Again, there was no low pH
enhancement of IHD-J in BS-C-1 cells; however, small enhancements
were found in some of the other cells (Figs. 4B, D). These results
suggested that the modes of VACV entry are affected by cell type as
well as virus strain.
Effects of soluble GAGs on VACV entry
We considered that if cell surface GAGs are important for IHD-J
entry, as suggested by the relative non-permissiveness of sog9 cells,
then entry into other cells should be inhibited by soluble GAGs. To test
this idea, IHD-J was incubated with heparin, heparan sulfate,
chondroitin sulfate or their combinations prior to adsorption on BS-
C-1 cells. At neutral pH conditions, 50 μg/ml of heparin and heparan
sulfate inhibited entry by 90 and 60%, respectively, whereas
chondroitin sulfate had no effect (Fig. 5B). There was no discernible
Fig. 2. Inhibition of VACV entry with endosomal acidiﬁcation inhibitor baﬁlomycin A1. BS-C-1 cells were pretreated with baﬁlomycin A1 for 1 h at 37 °C. Pretreated cells were then
incubated with (A) WR, (B) IHD-J, (C) Copenhagen, (D) Wyeth, and (E) Elstree luc recombinant strains of VACV in the presence of baﬁlomycin A1 at neutral pH for 1 h at 4 °C.
Unattached virus was removed, and the cells were washed and then exposed to pH 5 (ﬁlled squares, solid line) or pH 7.4 (open squares, dashed line) buffer for 3 min at 37 °C. Cells
were thenwashed and incubated at 37 °C at neutral pH for 1 h in the presence of baﬁlomycin A1. Untreated cells exposed to virus and the respective buffers were utilized as controls.
Error bars are plotted for each point, though in some the differences are too small to be resolved.
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tions, WR was less inhibited by these GAGs (Fig. 5A). In particular,
heparin reduced WR entry by only about 20% at neutral pH (Fig. 5A).
The sensitivity of WR to heparin was increased when the cells were
subjected to brief low pH treatment following neutral pH adsorption
(Figs. 5C, E), whereas the sensitivity of IHD-Jwas unaltered (Figs. 5D, F).
This result suggested that heparin inhibits WR entry through the
plasma membrane, which occurs after low pH treatment.
The above experiments were carried out at 50 μg/ml concentra-
tions of GAGs. To further compare the effects of heparin on IHD-J and
WR, we tested a range of concentrations. A 90% reduction of IHD-J
entry occurred at only 1 μg/ml, regardless of whether the cells were
exposed to low pH following adsorption (Fig. 6B). In the absence of
low pH exposure, heparin had no effect on WR entry (Fig. 6A). Brief
low pH treatment enhanced the sensitivity of WR for heparin but a
concentration of ∼50 μg/ml was required to reduce entry of WR by
50% even under these conditions (Fig. 6A).We also tested the heparin sensitivities of Copenhagen, Wyeth and
Elstree strains of VACV. Entry of Wyeth, like WR, was not strongly
inhibited by heparin; however, Copenhagen and Elstree like IHD-J
were inhibited by ∼90% compared to controls (Fig. 7). Thus, there
seemed to be a correlation between strains resistant to baﬁlomycin A1
and sensitive to heparin.
Effect of laminin on entry of VACV
Soluble laminin can reduce the ability of WR to bind and infect BS-
C-40 cells (a derivative of BS-C-1 cells that is propagated at 40 °C)
(Chiu et al., 2007). To conﬁrm and extend these results, we incubated
lamininwithWR and IHD-J MVs and determined luc expression at 1 h
as a measure of entry. Luc expression by WR was reduced by almost
50% whether or not the cells were exposed to low pH following virus
adsorption (Figs. 8A, C) whereas IHD-J expression was reduced about
25% (Figs. 8B, D). We also examined the effects of heparin as a control
Fig. 3. Effect of low pH treatment prior to adsorption on entry of VACV strains. (A)
VACV strains were pretreated with pH 5 (black bars) or pH 7.4 (gray bars) for 3 min.
Treated virus was incubated on BS-C-1 cells for 1 h at 4 °C at neutral pH. After
washing, cells were incubated at 37 °C for 1 h and luc values were measured. (B) The
fold enhancement of luc activity at low pH over neutral pH was calculated from data
in panel A. Error bars are plotted in each case, though in some the differences are too
small to be resolved.
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previous section i.e. only the low pH enhanced entry of WR was
reduced (Figs. 8A, C), whereas IHD-J entry was drastically reduced
after neutral or low pH treatments (Figs. 8B, D). Heparin and laminin
had additive effects on low pH enhanced WR entry (Figs. 8A, C) but
not on IHD-J (Figs. 8B, D).
Effect of heparin and laminin on binding of VACV to cells
Previous reports indicated that heparin reduces binding of WR to
cells (Chung et al., 1998), although this may be dependent on cell type
(Carter et al., 2005). We ﬁrst examined binding of WR and IHD-J
virions that had been incubated with heparin by determining the
recovery of infectious virus after adsorption to BS-C-1 cells. Following
washing, the cells were frozen and thawed and sonicated to release
bound virus. The amounts of infectious virus were then determined by
plaque assay. Inhibition of WR and IHD-J binding after heparin
treatment was 10 to 20% and 80 to 90%, respectively (data not shown).
The results suggested that heparin affects entry of IHD-J by reducing
binding to cells. However, there was a possibility that heparin
selectively inactivated IHD-J, rather than prevented binding to cells.
To eliminate the above possibility, we designed a more direct
analysis of binding. Puriﬁed WR and IHD-J MVs that contain green
ﬂuorescent protein (GFP) fused to the A4 core protein wereincubated with or without heparin and then allowed to adsorb to
BS-C-1 and sog9 cells. The amount of bound virus was measured by
ﬂow cytometry. Heparin reduced WR binding to BS-C-1 cells by
about 25%, whereas binding of IHD-J was at the background level
(Fig. 9A). WR also bound well to sog9 cells in the presence or
absence of heparin (Fig. 9B). Interestingly, IHD-J bound very poorly
to sog9 cells (Fig. 9B) providing an explanation for their low
infectivity in these cells. We also determined the effect of laminin on
binding of WR and IHD-J MVs to BS-C-1 cells. In each case, binding
was reduced about 25% (Fig. 9C).
Discussion
Enveloped viruses generally enter cells through the plasma
membrane at neutral pH or through endosomal vesicles at low pH
(Earp et al., 2005). VACV is unusual in that it can enter cells by either
route, which may contribute to its wide host range (Townsley et al.,
2006). Here we provide evidence that the relative utilization of these
pathways varies with the VACV strain and to some extent with the
host cell. Attachment and entry steps were experimentally separated
by allowing adsorption to occur at 4 °C for 1 h at neutral pH and
then raising the temperature to 37 °C for entry. Attachment was
measured either by recovery of infectious virus after washing and
lysing the cells or by ﬂow cytometry of recombinant VACV with GFP
fused to a core protein. Because the early transcription system is
packaged in virus particles and is activated when the core enters the
cytoplasm, detection of luc after only 1 h was used as a measure of
entry. Several parameters were measured: pH 5 activation before or
after virus adsorption at neutral pH, sensitivity to baﬁlomycin A1,
which prevents endosomal acidiﬁcation, and inhibition by soluble
GAGs and laminin. Analysis of the data revealed patterns in which
WR and IHD-J were distinctively different (Table 1). Copenhagen and
Elstree were similar to IHD-J, whereas Wyeth was intermediate.
Thus, WR was the only strain that exhibited enhanced entry by pH 5
treatment of virions before adsorption or pH 5 treatment of cell-
bound virions after adsorption, which correlated with sensitivity to
baﬁlomycin A1. Entry of IHD-J, Copenhagen and Elstree were neither
enhanced by pH 5 treatment nor inhibited by baﬁlomycin A1. These
results suggested that low pH endosomal entry was more important
for WR than for IHD-J, Copenhagen and Elstree strains and that the
latter strains rely more on direct entry through the plasma
membrane or an endosomal pathway that does not require low
pH. Wyeth, although not enhanced by pH 5 treatment, was inhibited
by baﬁlomycin A1. This apparent discrepancy, however, could be
explained by previous evidence of two low pH steps in VACV entry
(Townsley and Moss, 2007). Thus, if WR is activated with pH 5 buffer
and then neutralized prior to adsorption, there is no further low pH
enhancement after adsorption but the virus is still baﬁlomycin A1
sensitive (Townsley and Moss, 2007). Therefore, in this respect,
Wyeth resembles activated WR.
Heparin was previously shown to inhibit the binding of VACV
strain WR to cells, although the extent of this inhibition seemed to
vary in different reports (Carter et al., 2005; Chung et al., 1998;
Whitbeck et al., 2009). We found that entries of WR and Wyeth were
both relatively resistant to heparin, whereas the other strains were
more sensitive. Thus, 1 μg/ml of heparinwas sufﬁcient to inhibit IHD-J
entry by 90%, whereas inhibition of WR was minimal even at 50 μg/
ml. IHD-J was less sensitive to heparan sulfate than to heparin and
both WR and IHD-J were insensitive to chondroitin sulfate. Flow
cytometry demonstrated that heparin inhibited IHD-J entry at the step
of binding to cells.
The greater sensitivity of IHD-J to heparin compared to WR was
consistent with the differences in their abilities to infect sog9 cells,
which are GAG-deﬁcient (Banﬁeld et al., 1995). Thus, sog9 cells were
much more restrictive to IHD-J than to WR and this was shown to be
due to lower virus binding. Taken together, these results suggest that
Fig. 4. Entry of VACV in different cell types. The indicated cell types were incubated with WR (A, C) and IHD-J (B, D) at neutral pH at 4 °C. The cells were then washed and
treated with pH 5 (black bars) or pH 7.4 (gray bars) buffer for 3 min at 37 °C. The pH was neutralized and the cells were incubated in regular medium for 1 h and luc was
measured (A, B). The fold enhancement of low pH treatment was calculated (C, D). Error bars are plotted in each case, though in some the differences are too small to be
resolved.
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by direct fusion with the plasma membrane rather than through
endocytosis. The enhanced sensitivity of WR to heparin when the
adsorbed virus was brieﬂy treated with pH 5 buffer to accelerate entry
through the plasma membrane was consistent with this idea.
In addition to effects of VACV strain on entry, there were also
effects of cell type. We compared several cell lines (BS-C-1, RK-13,
HEKn, Vero, pTK2 and Sog9) with regard to low pH enhanced entry.
WithWR, each of the cell lines except HEKn showed between 2.6- and
4.6-fold enhancement. The sensitivity of WR to baﬁlomycin A1 could
be demonstrated in BS-C-1, RK-13 and HuTK-cells (Townsley et al.,
2006). Recently, Whitbeck et al. (2009) reported that baﬁlomycin A1
inhibitionwas stronger in BS-C-1 and B78H1 cells than Vero and HeLa
cells, though whether this was due to differences in the ability of the
drug to lower the pH or to differences in entrywere not determined. In
addition, they found that WR entry into HeLa, B78H1 and L cells was
more strongly inhibited by heparin than entry into Vero and BS-C-1
cells (Whitbeck et al., 2009).
The differences in entry of WR and other VACV strains are
remarkable and could be due to their continuous propagation on
diverse cell types as well as other factors. It is known that WR and
IHD-J differ in the release of extracellular virions due to a point
mutation in the A34R ORF (Blasco et al., 1993; Payne, 1979), but this
is unrelated to the difference in entry of MVs (A.C.T., unpublished).
We are currently in the process of swapping genes between WR and
IHD-J to determine the molecular basis for the differences in entry.
Once this is accomplished, we may be able to evaluate the effect of
mode of entry on virus distribution and pathogenicity in animal
models. It will also be interesting to determine the entry pathways of
isolates of other orthopoxviruses that have not been passaged
extensively in cell culture.Materials and methods
Cells and viruses
African green monkey kidney BS-C-1, rabbit kidney epithelial RK-
13, and potoroo kidney (PtK2) cells were maintained in minimum
essential medium with Earle's salts (EMEM, Quality Biological,
Gaithersburg, MD). Mouse sog9 cells were maintained in Dulbecco's
modiﬁed Eagle's medium. Media were supplemented with 10% fetal
bovine serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin, and
100 μg/ml streptomycin. Primary human epidermal keratinocytes
(HEKn) cells (Cascade Biologics, Portland, OR) were maintained in
the recommended medium. The following strains of VACV were
used: WR (ATCC VR-1354; GenBank accession number NC_006998),
IHD-J from S. Dales, Copenhagen from E. Paoletti, Elstree (Lister;
ATCC VR-1549) and Wyeth New York City Board of Health from a
Wyeth Laboratory seed stock. The recombinant VACV WR expressing
ﬁreﬂy luc via a synthetic early–late promoter (WRvFire) was
previously described (Townsley et al., 2006). Similar vFire recombi-
nants were made using the IHD-J, Copenhagen, Lister and Wyeth
strains. WR-A4GFP and IHD-J-A4GFP core-fusion recombinant
viruses were generated by the ampliﬁcation of GFP (accession
number AAG27429) and overlap extension PCR for fusion of the GFP
open reading frame to the N-terminal codon of A4L with WR and
IHD-J VACV genomic DNA as the template. To ensure efﬁcient
homologous recombination, ﬂanking sequences of A4L of at least
500 bp were appended to the termini of the PCR product. Cells were
infected with 0.1 plaque forming unit of WR or IHD-J per cell and at
1 h post infection transfected with 0.3 μg of gel-puriﬁed PCR product.
The infected and transfected cells were lysed during three freeze–
thaw cycles in a dry-ice bath and clonally puriﬁed 5 times by picking
Fig. 5. Effects of soluble GAGs on VACV entry. WR (A, C, E) and IHD-J (B, D, F) strains of VACV were pretreated with 50 μg per ml of heparin (HP), heparan sulfate (HS), chondroitin
sulfate (CS) and combinations of HP+HS and HP+CS for 30 min on ice. Without removal of the soluble GAGs, the treated virus was then incubated with BS-C-1 cells at 4 °C for 1 h at
neutral pH followed by a wash and treatment with (A, B) pH 7.4 buffer or (C, D) pH 5 buffer. Cells were then washed and incubated for 1 h at 37 °C at neutral pH, lysed and luc
measured. (E, F) Percent of control (virus mock incubatedwith GAGs) for each treatment was also determined from the data in panels A–D. Error bars are plotted in each case, though
in some the differences are too small to be resolved.
Fig. 6. Effect of heparin concentration on VACV entry. WR (A) and IHD-J (B) were incubated with 0 to 50 μg/ml of heparin for 30 min on ice and added to BS-C-1 cells at 4 °C for 1 h.
Cells were thenwashed and incubated with pH 5 or pH 7.4 buffer for 3 min at 37 °C followed by washing and incubation in regular medium at 37 °C for 1 h. Cells were then lysed and
luc activity measured. Error bars are plotted for each point, though in some the differences are too small to be resolved.
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Fig. 7. Effect of heparin on entry of VACV strains. (A) VACV strainswere treatedwith 50 μg/ml of heparin (white bars) or mock treated (black bars) for 30min on ice. Treated virus was
then added to cells and incubated at 4 °C for 1 h. Cells were then washed and incubated at 37 °C for 1 h followed by lysis and measurement of luc. (B) The percent RLU relative to
control of treated virus was also calculated. Error bars are plotted in each case, though in some the differences are too small to be resolved.
138 Z. Bengali et al. / Virology 389 (2009) 132–140GFP positive plaques on BS-C-1 cells. The inserted DNA of the
puriﬁed recombinant viruses was veriﬁed by sequencing.
Virus puriﬁcation
HeLa cells were infected with VACVWRvFire, IHD-JvFire, CopvFire,
ElstreevFire, WyethvFire, WR-A4GFP and IHD-J-A4GFP. MVs were
isolated at 48 h after infection as previously described (Earl et al.,
2001). Brieﬂy, infected cells were lysed by Dounce homogenization
and MVs were puriﬁed by sedimentation through two 36% (w/v)Fig. 8. Effect of laminin on entry of VACV. WR (A, C) and IHD-J (B, D) strains of VACV were
Treated virus was then incubated with BS-C-1 cells at 4 °C for 1 h followed by awash and trea
and incubated for 1 h at 37 °C, lysed and lucmeasured. (C, D) Percent of control (virusmock in
are plotted in each case, though in some the differences are too small to be resolved.sucrose cushions and banding once on a 25 to 40% (w/v) sucrose
gradient. Puriﬁed stocks were stored at −80 °C and sonicated on ice
for 1 min prior to infection.
Luc entry assay
Cells were seeded in 12-well plates and incubated at 37 °C
overnight. The cells were chilled for 10 min at 4 °C and virus allowed
to adsorb for 1 h at 4 °C at neutral pH. Unattached virus was
removed by washing. For pH activation, the cells were thenpretreated with 50 μg per ml of laminin (LN), HP and a combination of HP+LN. (A, B)
tment with pH 7.4 (gray bars) buffer or pH 5 buffer (black bars). Cells were thenwashed
cubated) for each treatmentwas also determined from the data in panels A, B. Error bars
Fig. 9. Effect of heparin and laminin on binding of WR and IHD-J to cells. Recombinant WR and IHD-J with GFP fused to the VACV A4 core protein were incubated with or without
heparin (A, B) or laminin (C) and adsorbed to HeLa (A, C) or sog9 (B) cells at 4 °C for 1 h. Unbound virus was removed by washing and the cells were harvested by scraping. The
amounts of virus bound to the cells were determined by ﬂow cytometry and the ratios of mean ﬂuorescence determined. The dashed lines indicate background ﬂuorescence. Error
bars are plotted in each case, though in some the differences are too small to be resolved.
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saline with Ca2+ and Mg2+ at pH 7.4 or adjusted with HCl and 1 mM
2-morpholinoethane-sulfonic acid to pH 5. The pH was then neu-
tralized andwashedwith EMEMcontaining2.5%FBS, 2mML-glutamine,
100 units/ml penicillin, and 100 μg/ml streptomycin (EMEM-2.5)
and incubated with 1 ml EMEM-2.5 at 37 °C for 1 h. Cells were then
harvested by washing with phosphate buffered saline (pH 7.4) and
incubation with 300 μl of Cell Culture Lysis Reagent (Promega,
Madison, WI) for 30 min at room temperature on an orbital shaker.
Luc assay was performed by adding 20 μl of cell lysate to 100 μl of luc
activity assay substrate (Promega), mixed, and chemiluminescence
was measured using a luminometer (Berthold Sirius, Bad Wilbad,
Germany).
Inhibition of endosomal acidiﬁcation
Cells were seeded in 12-well plates and treated with baﬁlomycin
A1 (Sigma, St. Louis, MO) at the indicated concentrations for 1 h at
37 °C. Cells were then cooled and infected as above with the exception
that baﬁlomycin A1 was present throughout the adsorption and
subsequent incubations.
Low pH treatment of virus prior to attachment
PuriﬁedMVswere incubated in phosphate buffered saline at pH 7.4
or 5 adjusted as described above in a ﬁnal volume of 50 μl for 3 min at
37 °C. The pH was neutralized with excess EMEM-2.5 and added to
cells for adsorption at neutral pH as described above.
Treatment of virus with soluble GAGs and laminin
Virus was treated with the indicated concentrations of heparin,
chondroitin sulfate, heparan sulfate, and laminin (Sigma) in EMEM-2.5Table 1
Differences in enhancement and inhibition of entry in VACV strains.
Enhancementa Inhibitiona
Pre-
adsorption
low pH
Post-
adsorption
low pH
Cellular
GAGs
Baﬁlomycin
A1
Soluble
heparin
Soluble
laminin
WR + + − + − +
Wyeth − − − + −
IHD-J − − + − + −
Copenhagen − − + − +
Elstree − − + − +
a - indicates an enhancement of less than 2-fold and inhibition of less than 25%.for 30min on ice.Without removing the GAGs, viruswas then added to
pre-chilled cells for adsorption at neutral pH as described above.
Plaque assay for determination of virus binding
Treated virus was added to pre-chilled cells at neutral pH and
incubated at 4 °C for 1 h. Cells were then washed immediately and
harvested by scraping. Cells were lysed by rapid freeze–thaw three
times and the lysates were diluted for plaque assay on BS-C-1 cells.
The number of plaques on untreated virus was used as control.
Flow cytometry assay for determination of virus binding
Recombinant strains of VACVwith GFP fused to the A4 core protein
were incubated with cells at neutral pH for 1 h at 4 °C at a multiplicity
of infection of 5. Unbound virus was washed with cold medium and
cells were harvested and ﬁxed in 2% paraformaldehyde and analyzed
with a FACSCalibur ﬂow cytometer using CellQuest (BD Biosciences)
and FlowJo Software (Tree Star, Inc, Ashland, OR).
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